MEETINGS - On Strategies in the Non/minimally Invasive Diagnostic Market (UK) December 1999:
This article was originally published in Clinica
A meeting on Strategies in the Non/Minimally Invasive Diagnostic Market will take place in London on December 6-7. It will cover European and global regulatory issues, strategic partnering, cost effectiveness of centralised laboratory testing, differing approaches to cancer diagnostics and risk stratification and diagnostic tools. Two workshops will also take place on Dec 8 - Strategic Planning for a Successful In Vitro Diagnostics Portfolio and Regulatory and Reimbursement Strategies in the Diagnostics Industry. Further details may be obtained from SMi in the UK. Tel: +44 20 7252 2222. Fax: +44 20 7252 2272.
You may also be interested in...
Azar says ACIP’s prioritization recommendations should carry weight, but states will be final arbiter of who is vaccinated.
Sanofi R&D head John Reed says the company has kept 95% of patients on its nearly 400 clinical trials, started 59 studies, and benefited from its in-house drug supply management.
The funding will be used to support clinical and preclinical development at its portfolio companies, with 8-10 programs in the clinic in 2021.